Adams Clinical Acquires InSite Clinical Research
December 11, 2024
Adams Clinical, a neuroscience-focused clinical trial site network, has agreed to acquire/partner with InSite Clinical Research to add inpatient and schizophrenia clinical trial capabilities and expand into Texas. The deal will also enable Adams to establish inpatient units at its Watertown, MA and Bronx, NY sites; Provident Healthcare Partners served as exclusive financial advisor to InSite.
- Buyers
- Adams Clinical, LLC
- Targets
- InSite Clinical Research
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Adams Clinical Acquires InSite Clinical Research
December 11, 2024
Healthcare Services
Adams Clinical has agreed to acquire InSite Clinical Research, a Dallas–Fort Worth clinical trial site specializing in inpatient and outpatient psychiatric and neurologic trials, expanding Adams' capabilities into inpatient psychiatry and Schizophrenia trials. The deal adds a Texas footprint for Adams and follows Adams' broader 2024 expansion; InTandem Capital Partners (Adams' investor) commented on the partnership.
-
InTandem Capital Partners Makes Growth Investment in Adams Clinical
May 21, 2024
Healthcare Services
InTandem Capital Partners, a healthcare-focused private equity firm, has partnered with the founders and management team of Adams Clinical, a Watertown, Massachusetts–based clinical trial site network focused on psychiatric and neurologic indications. The investment will support Adams Clinical’s growth and development of its site network and patient recruitment capabilities to better serve pharmaceutical sponsors and CROs.
-
Headlands Research Acquires Pharmasite Research
February 29, 2024
Healthcare Services
Headlands Research, a multinational network of clinical trial sites, has acquired Pharmasite Research, a Maryland-based clinical trial site focused on mental illness and central nervous system (CNS) disorders. The deal expands Headlands' therapeutic capabilities in mental health and extends its site network's reach in the Mid-Atlantic, bringing the network to 18 sites across the United States and Canada.
-
Atlas Clinical Research Acquires Suburban Research Associates
July 12, 2023
Healthcare Services
Atlas Clinical Research, a therapeutically-driven clinical site network and portfolio company of healthcare investor BPOC, has added Suburban Research Associates — a two-location psychiatric clinical research site in Media and West Chester, Pennsylvania — to its platform. The partnership will expand Atlas's site network and give Suburban access to centralized technology, operational support and broader sponsor/CRO connectivity to accelerate psychiatric clinical trials and patient reach.
-
PhaseWell Research Acquires Bio Behavioral Health
January 21, 2026
Healthcare Services
PhaseWell Research, a national clinical research site company, announced that Bio Behavioral Health has joined its network to expand access to neuropsychiatric and CNS clinical trials. The deal strengthens PhaseWell's community-based research capabilities and broadens patient access to complex clinical studies across its growing national footprint.
-
The IMA Group Acquires Clinical Trials of America
January 11, 2023
Healthcare Services
The IMA Group’s clinical research division, IMA Clinical Research, has acquired Clinical Trials of America (CTA), adding 10 site locations (four independent and six embedded) and expanding IMA’s reach in Louisiana and North Carolina. CTA will continue to operate under existing leadership, and the deal increases IMA’s clinical network and therapeutic capabilities to better serve sponsors and CROs; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.